Literature DB >> 17125249

Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning.

Ferenc Hollósy1, Klara Valkó, Anne Hersey, Shenaz Nunhuck, György Kéri, Chris Bevan.   

Abstract

The volume of distribution (VD) in humans of 179 known drug molecules (acids, bases, and neutrals) has been modeled using two biomimetic-binding measurements. The phospholipid binding (log K (IAM)) and the plasma protein binding (log K (HSA)) have been calculated from gradient HPLC retention times on immobilized artificial membrane (IAM) and on human serum albumin (HSA) columns, respectively. The log VD values showed good correlation with the compounds' relative binding to IAM and HSA as follows: log VD=0.44 log K (IAM)-0.22 log K (HSA)-0.66; n=179, r2=0.76, s=0.33, and F=272. It was also observed that positively charged molecules bind relatively more to IAM, while negatively charged ones bind more to HSA, in line with the empirical observation that bases tend to have a larger volume of distribution than acids. These results suggest that with the help of these two simple high throughput HPLC-based biomimetic binding measurements an important in vivo drug disposition property can be estimated for use in early drug discovery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125249     DOI: 10.1021/jm050957i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  19 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths.

Authors:  Michelle J Yoo; David S Hage
Journal:  J Sep Sci       Date:  2011-06-10       Impact factor: 3.645

3.  Identification and analysis of stereoselective drug interactions with low-density lipoprotein by high-performance affinity chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Anal Bioanal Chem       Date:  2012-02-22       Impact factor: 4.142

Review 4.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

5.  Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography.

Authors:  Sike Chen; Matthew R Sobansky; David S Hage
Journal:  Anal Biochem       Date:  2009-10-13       Impact factor: 3.365

6.  Studies of imipramine binding to human serum albumin by high-performance affinity chromatography.

Authors:  Michelle J Yoo; Quentin R Smith; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-10       Impact factor: 3.205

7.  Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography.

Authors:  Matthew R Sobansky; David S Hage
Journal:  Anal Bioanal Chem       Date:  2014-08-08       Impact factor: 4.142

8.  Estimating protein-ligand binding affinity using high-throughput screening by NMR.

Authors:  Matthew D Shortridge; David S Hage; Gerard S Harbison; Robert Powers
Journal:  J Comb Chem       Date:  2008-10-03

Review 9.  Prediction of drug disposition on the basis of its chemical structure.

Authors:  David Stepensky
Journal:  Clin Pharmacokinet       Date:  2013-06       Impact factor: 6.447

10.  Targeting the Endocannabinoid System for Neuroprotection: A 19F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA.

Authors:  Jianqin Zhuang; De-Ping Yang; Xiaoyu Tian; Spyros P Nikas; Rishi Sharma; Jason Jianxin Guo; Alexandros Makriyannis
Journal:  J Pharm Pharmacol (Los Angel)       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.